GTX (NASDAQ:GTXI)
3.51
+0.24 (7.34%)
| GTX (NASDAQ:GTXI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $18.75 | ||
| Open | $3.32 | 52 Week Low | $3.22 | ||
| Day High | $3.53 | P/E | N/A | ||
| Day Low | $3.27 | EPS | $-1.35 | ||
| Volume | 737,851 | ||||
| More GTXI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GSK | 2 | DNR | 2 |
| EAC | 2 | HGSI | 2 |
| ENP | 2 | LDK | 2 |
| VRTX | 2 | CIT | 2 |
| YRCW | 2 | FSNM | 1 |
| AVII | 1 | DGI | 1 |
Entities who have mentioned GTXI
- JPMorgan | View Related Stories »
- Citi | View Related Stories »
- Hellman & Friedman LLC | View Related Stories »
- Bankruptcy | View Related Stories »
- Deutsche Bank | View Related Stories »
- Scopia Capital | View Related Stories »
- Wachovia | View Related Stories »
- 13G | View Related Stories »
- UBS | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Cowen & Co | View Related Stories »
- B. Riley | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Fidelity Investments | View Related Stories »
- Lazard | View Related Stories »
View All Major News StreetInsider.com Major News for GTXI
- GTx (GTXI) Posts Q3 Loss of 35c, In-Line with Estimates
- GTx (GXTI) Says FDA Identified Two Deficiencies in the Complete Response Letter for Toremifene NDA
- GTx (GTXI) Reports Better-Than-Expected Q1 Loss
View All ReportsStreetInsider.com Reports on GTXI
- GTx (GTXI) Posts Q3 Loss of 35c, In-Line with Estimates
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Wells Fargo Downgrades GTx, Inc. (GTXI) to Market Perform; Lack of Near-Term Catalyst Keep Shares Range Bound
- Unusual 11 Mid-Day Movers 11/02: HGSI, EAC, IUSA, VRTX Higher; CIT, YRCW, GTXI, CPF Lower
- Cowen & Co Downgrades GTx, Inc (GTXI) to Underperform
View All Press ReleasesCompany Press Releases on GTXI
- GTx Announces Corporate Presentation at Lazard Capital Markets Annual Healthcare Conference
- GTx, Inc. Reports Third Quarter 2009 Corporate Results
- GTx, Inc. Announces Third Quarter 2009 Corporate Results Conference Call and Webcast
- GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug Application
- GTx to Host Conference Call and Webcast to Provide Update on Status of Toremifene 80 mg New Drug Application
StreetInsider Reports on GTXI by Category
View All BlogsBlogs on GTXI
- Equities Update: Upward Mobility
- October FDA Calendar Stocks: Tricks or Treats?
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
- Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
- 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
View All FilingsSEC Filings on GTXI
- Form SC 13G/A GTX INC /DE/ Filed by: FMR LLC
- Form 10-Q GTX INC /DE/ For: Sep 30
- Form 8-K GTX INC /DE/ For: Nov 09
- Form 8-K GTX INC /DE/ For: Nov 02
- Form 4 GTX INC /DE/ For: Oct 01 Filed by: HYDE JOSEPH R III
Comments on GTXI
No comments are currently available.
